Jan 12, 2021 / 01:20PM GMT
Anupam Rama - JPMorgan Chase & Co, Research Division - VP and Analyst
Welcome, everyone, to the 39th Annual JPMorgan Healthcare Conference. My name is Anupam Rama. I'm one of the senior biotech analysts here at JPMorgan. I'm joined by Tessa Romero and Matt Bannon from the team.
Our next presenting company is Amicus and presenting on behalf of the company, we have, CEO, John Crowley. Before I turn it over to John, (Operator Instructions)
With that, I'll pass it over to you, John.
John F. Crowley - Amicus Therapeutics, Inc. - Chairman & CEO
Great. Good morning, Anupam. Good morning, everybody. Thank you, JPMorgan, for hosting. I will mention that I'll be making forward-looking statements, and we'll refer you to our forward-looking statements section on Slide 2.
Let me begin though on Slide 3, and this is really the foundation of Amicus. Again, what we've been striving to achieve over the last several years and now looking out to the future is to build a great biotechnology company. And this slide on 3 here really shows you the
Amicus Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Feb 07, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers